Page 24 - Alkermes News Today

— Company Grants Teva a License to Market Generic VIVITROL Beginning in January 2027 — DUBLIN, Aug. 30, 2023 /PRNewswire/ -- Alkermes plc  announced today that the company entered into...

U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

Shares of Alkermes PLC jumped 10% Wednesday after the Dublin-based biopharma company announced a settlement of patent litigation with Teva Pharmaceuticals...

(RTTNews) - Alkermes plc (ALKS) has entered into a settlement agreement with Teva Pharmaceuticals USA, Inc. to resolve the ongoing patent litigati...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including HP slipping on slower expected growth, Alkermes settling a…

Objective To systematically assess credibility and certainty of associations between cannabis, cannabinoids, and cannabis based medicines and human health, from observational studies and randomised controlled trials (RCTs). Design Umbrella review. Data sources PubMed, PsychInfo, Embase, up to 9 February 2022. Eligibility criteria for selecting studies Systematic reviews with meta-analyses of observational studies and RCTs that have reported on the efficacy and safety of cannabis, cannabinoids, o...

Postdoc and Postgrad Positions in Computational Biology, Human Genetics, and Molecular Epidemiology job in New Haven, Connecticut with Yale University School of Medicine. Apply Today.

It is already changing how pharma companies make drugs

It is already changing how pharma companies make drugs | Business

Pharmacists' expertise is invaluable to prescribers who are unfamiliar with opioid use disorder treatment protocols.